only the start

UCM with its non invasive ultrasonic cardiac output monitor has huge potential.
Every Hospital in the world with cardiac care costs floating in the multi billions not millions, would be eager to reduce the costs of patient monitoring.
This is a proven device, with no side effects and low risk with its non invasive application.
USCOM have not even scratched the surface in Asia, they have only this week launched the product in Europe and wait to FDA approval is cleared in the US later this year. Step aside Cochlear.
Australia have numerous hospitals installed for trial, with positive results and sales orders imminent.
The company projections, even after penetrating a small percentage of the target market is mind blowing.
China alone, which has already made the first buy orders have in excess of 1,000,000 hospitals, as possible target markets. Imagine if only 5% penetration is achieved.that is 50000 unit order for starters, not even touching Taiwan, Korea and Japan where early orders have also been recived.
I will leave it to your imagination from here, do your own research.